4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity
about
sameAs
4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityThe costimulation-regulated duration of PKB activation controls T cell longevityAdjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activityCostimulatory pathways in transplantation.Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor.Altered T cell responses in children with autism.4-1BB ligand enhances tumor-specific immunity of poxvirus vaccinesAdjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer.Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.Costimulation blockade and its possible future use in clinical transplantation.Recombinant Salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL.Aging Converts Innate B1a Cells into Potent CD8+ T Cell InducersRetroviral immunology: lessons from a mouse model.Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivoCD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells.Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities.4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells.Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.Practical considerations for chimeric antigen receptor design and delivery.Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.
P2860
Q27012963-AE3A3907-2C89-4FED-9838-50583A61E38AQ28239478-D14795DE-9A29-4AB9-B18F-C2ADA26D7F96Q33624219-6C0A4A94-87D8-476A-A8A6-2FDEA39949EEQ34106843-8FEF1908-DC4E-423A-A19F-35CBCD12FAE4Q34187594-7342F348-4F88-4C32-A0AA-D4E5C5D78399Q34485933-6D87E3C7-5F61-4DB0-9848-B7E56DE5AE6BQ34577189-A9F74963-6709-4D83-A576-CE0401BC760AQ35781892-04D6975D-165B-4320-8BEC-0BAF031DBEACQ36174218-EC8BD284-0F11-4FE0-8059-297A339F83B6Q36324254-3E5EDDB3-0AAF-4920-9900-3DF669A87F6CQ36360561-E92A81B8-E931-4982-ADCE-874DC5E6D055Q36371828-585BA687-9680-4E61-86F6-A666BAD0E262Q36382421-5342BCA8-8121-4DD7-8BEA-1FEB6D18BFE4Q36570561-FB0AFA62-BCFC-49F3-A077-CBA4D86681D7Q36707828-D9CC9553-AC9A-4229-8E55-88B0EAED3CC1Q36767874-5D1E2485-1E04-4B69-971C-4B8F15358D0BQ37003684-9025E70C-9EB6-4BAC-BF91-D0C88D8BB98EQ37069554-071168ED-6ECE-4F84-9C65-8791EDD3C60CQ37159129-6A9DCC3B-6331-4AB3-BE85-83C9EC206C09Q37401696-EAA43BD5-53DF-44B7-B5E2-A84B3758CB11Q37574566-43CEF464-7A82-4D30-BE48-705485EA5F17Q38152797-BE39926E-0B44-4E3C-B705-89CA93BD5F06Q38511041-96CEA063-3187-4E1A-913A-2C3C76C2AD48Q39084950-38A5DD99-0D87-4207-97AB-A4A7BACE3F79Q39111432-4545536F-A7FA-4F59-A73C-7CA4EC55B56DQ39452134-079B5DC8-ED2C-4684-A127-969CB34C4019Q44493927-C9BF935F-1343-4875-9348-CA7DD32F181FQ45348994-BBDE258F-F70C-4385-9D22-AA0F2F491900Q45441936-9343A67C-D70B-448A-BA0C-BCC70C5EA0E4Q45868559-2E6FA817-0587-48EB-9EE0-87D3532BB4CFQ48020828-B8794FCF-8BD1-46D8-8D1E-DCE150CDD935
P2860
4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@ast
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@en
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@nl
type
label
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@ast
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@en
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@nl
prefLabel
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@ast
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@en
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@nl
P2093
P2860
P1476
4-1BB (CD137) controls the clo ...... he development of cytotoxicity
@en
P2093
David Cooper
Michael Croft
Pratima Bansal-Pakala
P2860
P356
10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO;2-X
P407
P577
2002-02-01T00:00:00Z